Welcome to the Collaborative Ocular
The Quality of Life Study was added as a component of the COMS in 1995.
It is designed to measure the effect of choroidal melanoma on health- and
vision- related quality of life and to determine whether quality of life
differs in patients who are treated by radiation (I-125 plaque)
versus enucleation (removal of the eye).
Melanoma Quality Of Life Study
There are two parts to the Quality of Life Study
- Prospective Study
- From January 1995 through July 1998, newly diagnosed patients
with medium-sized tumors who enrolled in the COMS were
eligible to enroll in the QOLS. They had their
first quality of life interview before they were randomized
- In addition to this baseline interview, patients are interviewed
6 months after enrollment and treatment, and once each year
from then on, around the time of the anniversary of their enrollment
- Cross-sectional Study
- Starting in 1997, patients who where diagnosed with choroidal melanoma
and enrolled in the COMS trial for medium-sized tumors prior to 1995,
and patients who enrolled after 1995 but elected not to participate
in the QOLS at that time, were invited to participate in the QOLS
- These patients are interviewed once each year around the time
of the anniversary of their enrollment in the COMS.
Copyright 2004. The Collaborative Ocular Melanoma-Quality Of Life Study.